Randomised study with docetaxel, cisplatin and cyclophosphamide vs docetaxel and carboplatin as first line chemotherapy with advanced or metastatic ovarian cancer
Phase of Trial: Phase II
Latest Information Update: 13 Aug 2012
At a glance
- Drugs Carboplatin; Cisplatin; Cyclophosphamide; Docetaxel
- Indications Ovarian cancer
- Focus Adverse reactions; Therapeutic Use
- Acronyms OCSTUD
- 31 Aug 2018 Biomarkers information updated
- 01 Jun 2011 Actual end date (Nov 2010) added as reported by ClinicalTrials.gov.
- 01 Jun 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.